Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Pruzanski

Showing results (71-80 of 210) with videos related to

Pageof 21
Sort By:
Agents and Actions|July 1, 1988
Extracellular phospholipase A2: causative agent in circulatory collapse of septic shock?P Vadas, W Pruzanski, E Stefanski
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|May 23, 2015
Diverse activity of human secretory phospholipases A2 on the migration of human vascular smooth muscle cellsW Pruzanski, J Kopilov, A Kuksis
Inflammation|June 1, 1986
Influence of plasma proteins on activity of proinflammatory enzyme phospholipase A2P Vadas, E Stefanski, W Pruzanski
The Journal of Rheumatology|April 1, 1983
Modulation of phagocytosis and bactericidal activity of human polymorphonuclear and mononuclear phagocytes by antiarthritic agentsW Pruzanski, S Saito, G DeBoer
The Journal of Laboratory and Clinical Medicine|November 1, 1991
A predictive model for the clearance of soluble phospholipase A2 during septic shockP Vadas, W Pruzanski, V Farewell
The Journal of Rheumatology|May 1, 1981
Neuroarthropathy (Charcot joints) in familial amyloid polyneuropathyW Pruzanski, M Baron, R Shupak
Blut|November 1, 1981
New antigenic determinant (Sa) on human lymphocytes and phagocytesW Pruzanski, M Armstrong, D Roelcke
The Journal of Investigative Dermatology|April 1, 1986
Inflammatory effect of intradermal administration of soluble phospholipase A2 in rabbitsW Pruzanski, P Vadas, V Fornasier
Life Sciences|February 11, 1985
Characterization of extracellular phospholipase A2 in rheumatoid synovial fluidP Vadas, E Stefanski, W Pruzanski
Agents and Actions|November 1, 1986
Potential therapeutic efficacy of inhibitors of human phospholipase A2 in septic shockP Vadas, E Stefanski, W Pruzanski
Pageof 21

Showing results (71-80 of 210) with videos related to

Sort By:
Pageof 21
Agents and Actions|July 1, 1988
Extracellular phospholipase A2: causative agent in circulatory collapse of septic shock?P Vadas, W Pruzanski, E Stefanski
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|May 23, 2015
Diverse activity of human secretory phospholipases A2 on the migration of human vascular smooth muscle cellsW Pruzanski, J Kopilov, A Kuksis
Inflammation|June 1, 1986
Influence of plasma proteins on activity of proinflammatory enzyme phospholipase A2P Vadas, E Stefanski, W Pruzanski
The Journal of Rheumatology|April 1, 1983
Modulation of phagocytosis and bactericidal activity of human polymorphonuclear and mononuclear phagocytes by antiarthritic agentsW Pruzanski, S Saito, G DeBoer
The Journal of Laboratory and Clinical Medicine|November 1, 1991
A predictive model for the clearance of soluble phospholipase A2 during septic shockP Vadas, W Pruzanski, V Farewell
The Journal of Rheumatology|May 1, 1981
Neuroarthropathy (Charcot joints) in familial amyloid polyneuropathyW Pruzanski, M Baron, R Shupak
Blut|November 1, 1981
New antigenic determinant (Sa) on human lymphocytes and phagocytesW Pruzanski, M Armstrong, D Roelcke
The Journal of Investigative Dermatology|April 1, 1986
Inflammatory effect of intradermal administration of soluble phospholipase A2 in rabbitsW Pruzanski, P Vadas, V Fornasier
Life Sciences|February 11, 1985
Characterization of extracellular phospholipase A2 in rheumatoid synovial fluidP Vadas, E Stefanski, W Pruzanski
Agents and Actions|November 1, 1986
Potential therapeutic efficacy of inhibitors of human phospholipase A2 in septic shockP Vadas, E Stefanski, W Pruzanski
Pageof 21